You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 16, 2024

Details for Patent: 8,741,920

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,741,920 protect, and when does it expire?

Patent 8,741,920 protects ZELBORAF and is included in one NDA.

This patent has twenty-nine patent family members in sixteen countries.

Summary for Patent: 8,741,920

Title:	Process for the manufacture of pharmaceutically active compounds
Abstract:	The present invention relates to a composition comprising the compound of formula (1), ##STR00001## and the compound of formula (B), ##STR00002##
Inventor(s):	Hildbrand; Stefan (Gelterkinden, CH), Mair; Hans-Juergen (Loerrach, DE), Radinov; Roumen Nikolaev (West Caldwell, NJ), Ren; Yi (Shanghai, CN), Wright; James Anderson (Cedar Grove, NJ)
Assignee:	Hoffmann-La Roche, Inc. (Nutley, NJ)
Application Number:	13/613,017
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 8,741,920

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Hoffmann La Roche	ZELBORAF	vemurafenib	TABLET;ORAL	202429-001	Aug 17, 2011		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,741,920

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	09167054	Aug 3, 2009
	09175101	Nov 5, 2009

International Family Members for US Patent 8,741,920

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010280848	⤷ Sign Up
Brazil	112012002251	⤷ Sign Up
Canada	2768632	⤷ Sign Up
China	102574799	⤷ Sign Up
China	103601725	⤷ Sign Up
China	104910150	⤷ Sign Up
Denmark	2462116	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.